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A cell cycle-dependent mechanism of renal tubule epithelial antiproliferative agent in epithelial cells is transforming
cell hypertrophy. The response of renal epithelial cells to injury growth factor-b (TGF-b).
can include hyperplasia (increase in cell number), apoptosis If the growth response to the experimental maneuver
(cell death), antiproliferation (growth arrest), or hypertrophy
is one in which the individual cells physically enlarge,(cells physically enlarge). Examining cell size and the pro-
then that growth response is one of hypertrophy. Intein:DNA ratio can differentiate between the growth response
patterns, but it is proposed that the degree of activation of cultured renal tubule epithelial cells, numerous condi-
cyclin D kinase in the late G1 phase of the cell cycle differenti- tions have been associated with an increase in cell size,
ates between hyperplasia and hypertrophy. including exposure to mitogens, such as angiotensin II,
EGF, insulin, and hydrocortisone in combination with
TGF-b, glucose, and increased concentrations of ammo-
Kidney size increases in response to a variety of patho- nium chloride [1, 2].
logic or abnormal situations, including the loss of renal When studying cell growth, these terms (hyperplasia,
mass because of ablation or nephron dropout, diabetic hypertrophy, antiproliferation, and apoptosis) should be
nephropathy, chronic metabolic acidosis, chronic potas- used very specifically. An increase in kidney size does
sium deficiency, a chronic increase in protein intake, not necessarily correlate with a hypertrophic growth re-
and pregnancy [1, 2]. In all of these conditions except sponse. It is possible for kidney size to increase in re-
pregnancy, the increase in kidney size is associated with sponse to hyperplasia, an increase in water content of
an increase in the size of the renal epithelial cells of the the kidney, such as occurs in pregnancy, cells infiltrating
into the kidney, or to a true increase in cell size.tubule. Various nephron segments hypertrophy in these
In assaying cell growth, there are indices that are capa-conditions; however, in all of these cases, there is an
ble of differentiating between the various growth pat-increase in proximal tubule epithelial cell size.
terns. If following a growth signal hyperplasia is theThere are specific terms used to describe cell growth.
resulting growth response, then this growth responseWhen a cell population is studied, if the experimental
will be marked by increases in both DNA and proteinmaneuver leads to an increase in cell number, the growth
synthesis and an increase in both the protein and DNAprocess is hyperplasia. This is the typical growth response
contents of the sample so that there will be no changefollowing exposure to mitogens, such as the growth fac-
or perhaps even a small decrease in the ratio of pro-tors platelet-derived growth factor and epidermal growth
tein:DNA. Accompanying this lack of effect on the pro-factor (EGF).
tein:DNA ratio will be no effect on cell size. One qualify-If growth is arrested by the experimental maneuver,
ing statement should be made here. If the majority ofthen the growth process is one of antiproliferation. The
the cells in the population being studied have recentlyterm antiproliferation is reserved for the specific situa-
exited mitosis, then it is possible that both cell size andtion in which further growth is prevented. Ultimately,
the protein:DNA ratio will be slightly smaller than thethis will result in a decrease in cell number compared
control population. This is because cells that have justwith a control population of cells. Antiproliferation does
exited mitosis need to accumulate a full complement ofnot refer to a decrease in cell number caused by cell
cytoplasm before they achieve a mature cell size.death. That is the process of apoptosis. The prototype
When the growth signal is one that leads to a hypertro-
phic growth response, then the growth pattern will be
associated with an increase in protein content with orKey words: renal mass, cell antiproliferation, growth response, hyper-
trophic growth, epithelial cell. without a decrease in DNA content. Regardless of the
effect on DNA, there will always be an increase in the 1999 by the International Society of Nephrology
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Table 1. Expected growth patternprotein:DNA ratio and an increase in cell size. However,
there will not be an increase in DNA synthesis. Hyperplasia ↑ in protein synthesis and content
↑ in DNA synthesis and contentThus, studies that are comparing a hyperplastic to a
No change or small ↓ in Protein:DNAhypertrophic growth process typically use DNA synthe- content ratio
sis, the protein:DNA ratio, and cell size as markers to No change or a small ↓ in cell size
Hypertrophy ↑ in protein content, with or without an ↑ in proteindifferentiate between the two growth patterns. The ex-
synthesispected patterns are shown in Table 1. No change or a ↓ in DNA synthesis and content
↑ in Protein:DNA content ratio
↑ in cell size
CELL CYCLE-DEPENDENT MECHANISM
OF HYPERTROPHY
The initial studies that we performed used cultured
cells, both primary cultures of rabbit proximal tubule prevent the EGF-induced growth process, studies were
cells and a continuous cell line, NRK-52E cells, a normal done to demonstrate that early mitogen-induced re-
renal epithelial cell line. In all protocols tested, the re- sponses occurred in both the EGF- and EGF 1 TGF-
sults were the same between the two types of cells. b1–treated cells [6]. Three studies were performed. The
Previous laboratories had demonstrated that renal tu- first examined c-fos mRNA abundance in control, EGF-,
bule epithelial cells hypertrophy following exposure to TGF-b1–, and EGF 1 TGF-b1–treated cells. TGF-b1
the combination of a growth factor and an antiprolifera- alone had no effect on c-fos mRNA abundance, whereas
tive cytokine, such as TGF-b1 [3–5]. Our first studies both the EGF- and EGF 1 TGF-b1–treated cells demon-
were done to confirm that both primary cultures of rabbit strated a transient increase in c-fos mRNA abundance,
proximal tubule cells and the NRK-52E cell line also which peaked at 30 minutes. This rapid, transient in-
hypertrophied under these conditions. A time course of crease in c-fos abundance is typical of cells crossing the
exposure to EGF and/or TGF-b1 was done in which it mitosis/G1 or G0/G1 interface. Thus, the immediate mito-
was demonstrated that EGF leads to a hyperplastic gen-induced response was not modified by TGF-b1 and,
growth response: TGF-b1 has an antiproliferative effect therefore, is not responsible for the conversion from a
on cell growth, and the combination of the two leads to hyperplastic to hypertrophic growth response.
a hypertrophic growth response [1, 2, 6, 7]. Thus, we The second study examined the effect of EGF and
reconfirmed that the combination of a mitogen plus an TGF-b1 on protein synthesis, another event that typi-
antiproliferative cytokine leads to the development of cally occurs shortly after cells enter the G1 phase.
hypertrophy in renal tubule epithelial cells. In addition, 3H-phenylalanine incorporation was used as the marker
these studies provided a situation in which we could for protein synthesis. As with the c-fos studies, TGF-b1
simultaneously compare a hyperplastic to a hypertrophic alone had no effect on protein synthesis, whereas both
growth mechanism. the EGF- and EGF 1 TGF-b1–treated cells demon-
Compared with control cells, the hyperplastic growth strated a robust increase in protein synthesis.
response was associated with an increase in both protein The third study looked at the regulation of cyclin E
and DNA synthesis and content, no change in the pro- protein abundance in both growth responses. Changes
tein:DNA ratio, and no change in cell size. By compari- in cyclin E protein abundance represent events that are
son, the hypertrophic growth response was associated occurring in the mid-late G1 period, and thus occur later
with an increase in protein content, a decrease in DNA than either the effects on c-fos mRNA abundance or the
synthesis, and an increase in both the protein:DNA ratio initiation of protein synthesis. Once again, the observa-
and the cell size. Thus, the hyperplasic growth response tion was the same: no effect of TGF-b1 alone on cyclin
(exposure to EGF alone) differs from the hypertrophic E protein abundance, but an increase in both EGF- and
growth response (exposure to EGF 1 TGF-b1) by inhib- EGF 1 TGF-b1–treated cells. Thus, the three studies
demonstrated that although the conversion of a hyper-iting the EGF-induced increase in DNA synthesis, with-
out effecting the EGF-induced increase in protein syn- plastic to hypertrophic growth response blocks move-
ment into the S phase, it does not prevent the earlythesis. Cell cycle analysis, using propidium iodide, was
performed to confirm the DNA synthesis experiments. events associated with mitogenic stimulation. Thus, the
conversion must occur in the late G1 phase. A require-It was found that cells undergoing a hyperplastic growth
response have more than one copy of DNA, whereas the ment for the cells to have progressed up to the late G1
period is suggested by the studies in which cells werehypertrophied cells have a single copy of DNA. Taken
together, these studies suggest that the development of exposed to TGF-b1 alone. In this situation, the cells do
not hypertrophy.hypertrophy is associated with the modification of an
EGF-induced growth process. Having demonstrated that the hypertrophying cells
did enter and need to enter G1, we next looked at eventsTo confirm that TGF-b1 modified but did not entirely
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that occur at the G1/S interface [6, 8]. pRB, the retino- ber of cdk2/cyclin E complexes, (c) failure to activate
the kinase, or (d) association of a cyclin kinase inhibitorblastoma protein, plays a key role in progression across
the G1/S interface. As a cell enters G1, pRB is unphos- (CKI) with cdk2/cyclin E complexes that do form. We
tested all of these possibilities and found the followingphorylated. Early in G1, cyclin D kinase phosphorylates
some of the sites on pRB, rendering the protein “active” [8]: TGF-b1 had no effect on EGF-induced increases
in either cdk2 or cyclin E protein abundances. Thus, ain the sense that it can now bind the transcription factor
E2F and prevent transcription of genes required for deficiency in subunit abundance is not responsible for
the decrease in kinase activity. Likewise, TGF-b1 had noDNA synthesis in S phase. Late in G1, cyclin E kinase
further phosphorylates pRB. In this hyperphosphory- effect on the abundance of Cdc25A, the duel-specificity
phosphatase that is responsible for removing the N-ter-lated state, the protein is “inactive” in that it can no
longer bind E2F, and thus, transcription of S-phase– minal Tyr and Thr phosphate residues on cdk2. The
removal of these phosphate molecules is necessary torequired genes proceeds. It is the activation of cyclin E
kinase, followed by the accumulation of S-phase– activate the kinase [9–11]. Because in many cell systems,
Cdc25A activity is regulated by regulating its proteinrequired genes that marks the transition across the re-
striction point in late G1 and entrance into S phase. abundance, this observation suggests that preventing
N-terminal Tyr and Thr dephosphorylation is not re-In affinity-purified lysates, EGF alone lead to a large
increase in the abundance of the hyperphosphorylated sponsible for the reduction in kinase activity [12–14].
Transforming growth factor-b1 did, however, signifi-form of pRB, consistent with a hyperplastic growth re-
sponse. In the EGF 1 TGF-b1–treated cells, the abun- cantly decrease the number of cdk2/cyclin E complexes
that formed. This was determined by assaying the abun-dance of hyperphosphorylated pRB was the same as in
control cells. Thus, TGF-b1 blocked the entire EGF- dance of cdk2 that coprecipitated with cyclin E. A reduc-
tion in complex abundance could clearly provide a mech-associated hyperphosphorylation of pRB, and all of the
pRB protein remained in the hypophosphorylated, ac- anism by which kinase activity could be reduced. In
addition, in complexes that did form in EGF 1 TGF-tive form. To determine whether it is necessary for pRB
to be active, studies were done using the HPV 16 onco- b1–treated cells, there was an increase in the abundance
of the CKI p57Kip2 associated with the complexes, com-protein E7, which binds the hypophosphorylated form
of pRB, rendering it “inactive.” In the presence of the pared with control cells. Increased association of an in-
hibitor provides another mechanism to explain the re-HPV16 E7 protein, TGF-b1 was not able to convert
the EGF-induced hyperplasia to hypertrophy. In fact, in duction in kinase activity.
Taken together, these studies demonstrate that EGF 1these EGF 1 TGF-b1–treated cells, the growth response
was hyperplasia. Complexing another cell cycle regula- TGF-b1–mediated hypertrophy is due to the combina-
tion of two events. First, EGF causes the cells to entertory protein, p53, with another HPV 16 oncoprotein, E6,
had no effect on the ability of TGF-b1 to convert EGF- the cell cycle, initiate protein synthesis, activate cyclin
D, and phosphorylate pRB sufficiently to activate theinduced hyperplasia to hypertrophy. Thus, it is clear that
the development of hypertrophy requires mitogen- protein. TGF-b1 does not modify any of these EGF-
mediated events. Second, TGF-b1 blocks EGF-inducedinduced entrance into G1, followed by an arrest of cell
cycle progression at the G1/S interface and that pRB activation of cyclin E kinase, preventing hyperphosphor-
ylation and thus inactivation of pRB. The consequencemust be active for hypertrophic growth to occur.
Taken together, the studies demonstrated that it is a of this event is that cell cycle progression is arrested,
and the cells continue to reside in late G1. It is clear thatlate G1 event that is being modified by TGF-b1 and
is necessary to convert hyperplasia to hypertrophy. As both of these events must occur. If the cells do not enter
the G1 phase, as would occur in the absence of mitogenicregulation of pRB activity is governed by the G1 kinase,
we next measured cyclin D and E kinase activities [8]. stimulation, or if cell cycle progression is not arrested at
the G1/S interface, as would occur when pRB is inacti-As expected, if a late G1 event is what is responsible for
the development of hypertrophy, TGF-b1 had no effect vated, the resulting growth pattern would be antiprolifer-
ation or hyperplasia, respectively, but not hypertrophy.on the EGF-induced increase in cyclin D kinase activity,
assayed in cyclin dependent kinase 4 (cdk4), cyclin D1, Based on these observations, we propose a model for
the development of hypertrophy that we refer to as cellcyclin D3, and cdk6 immunoprecipitates. However,
TGF-b reduced the EGF-induced increase in cyclin E cycle dependent (Fig. 1). Following either a hyperplastic
or hypertrophic growth stimulus that causes the cells tokinase activity by greater than 75% [8]. These studies
further confirm that the development of hypertrophy enter the cell cycle, cyclin D kinase is activated and
protein synthesis increases. Because both hyperplasiaoccurred by modifying an EGF-induced late G1 event.
Inhibition of cyclin E kinase activity could be caused and this form of hypertrophy result in an increase in the
physical size of the cell, either transiently in the case ofby either (a) a decrease in the availability of the kinase
subunits (cdk2 and cyclin E), (b) a decrease in the num- hyperplasia or permanently in the case of hypertrophy,
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Fig. 1. Model for the role of the G1 kinases in hyperplasia and cell cycle-dependent hypertrophy (reprinted with permission from Experimental
Nephrology, S. Karger AG Basel) [2].
we propose that cyclin D kinase is initiating and mediat- made on isolated proximal tubules; BrdU incorporation
ing the increase in physical growth. into cortical proximal tubules is used as a marker for
It is then the events of the late G1 phase that differenti- DNA synthesis and cyclin D and E kinase activities are
ate hyperplasia from cell cycle-dependent hypertrophy. measured on either cortical homogenate or isolated
If cyclin E kinase is activated sufficiently to phosphory- proximal tubule homogenate. For the kinase activities,
late pRB fully, the protein is inactivated, S-phase re- the results are the same for the cortical and isolated
quired genes are transcribed, the cell progresses into S proximal tubule homogenates, demonstrating that changes
phase, and hyperplasia is the resulting growth pattern. in cortical kinase activity reflect changes in proximal
However, if cyclin E kinase is not activated sufficiently tubule kinase activity. Nevertheless, most kinase studies
to phosphorylate pRB, then the protein remains in its are done on isolated proximal tubule preparations.
active state, the S-phase required genes are not tran- Compensatory renal growth following the loss of renal
scribed, cell cycle progression is arrested, and under the mass is induced by uninephrectomy. This form of growth
continued activity of cyclin D kinase, the cells continue is associated with a progressive increase in kidney weight
to grow and remain enlarged and hypertrophy is the and the protein:DNA ratio of isolated proximal tubules.
resulting growth pattern. The compensatory growth period is associated with the
activation of cortical cyclin D kinase activity four-days
postnephrectomy, but a return toward baseline levels atMECHANISM OF RENAL GROWTH
FOLLOWING THE LOSS OF RENAL MASS days 7 and 14. In contrast, cortical cyclin E kinase activity
is increased 2 days postnephrectomy, remains elevatedThe in vitro EGF 1 TGF-b1 hypertrophy model pro-
at 4 and 7 days, and returns to baseline levels at 14 days.vides a mechanism for examining the development of
Despite activation of cyclin E, there is no increase inhypertrophy in vivo. Based on the patterns of G1 kinase
BrdU incorporation of proximal tubules, thus demon-activity, DNA synthesis, and the protein:DNA content
strating that insufficient cyclin E kinase activity was pres-ratio, we are able to differentiate hyperplasia from cell
ent to inactivate pRB and permit movement into S phase.cycle-dependent hypertrophy and to determine under
A growth pattern in which there is an increase in thewhat conditions renal epithelial cells hypertrophy. Fol-
protein:DNA ratio and no increase in BrdU incorpora-lowing uninephrectomy and in other in vivo growth mod-
els, the protein and DNA content measurements are tion is characteristic of a purely hypertrophic growth
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(abstract; Liu and Preisig, J Am Soc Nephrol 8:424A, which is evident at day 2. At this time point, both cyclin
1997). D and E kinase activities are increased. Cyclin D kinase
To determine if the small increase in cyclin E kinase activity remains elevated at days 5 and 10, whereas cyclin
activity is necessary for the development of hypertrophy, E kinase activity is inhibited compared with control rats
rats were given Roscovitine, a cdk2/cyclin E kinase inhib- at both days 5 and 10. BrdU incorporation is only in-
itor (abstract; Liu and Preisig, J Am Soc Nephrol 9:444A, creased at day 2, at which time both cyclin D and E
1998). In the presence of Roscovitine in sham rats, base- activities are increased. The profile of BrdU incorpora-
line cyclin E kinase is inhibited. In nephrectomized rats, tion matches the activation and then inhibition of cyclin
Roscovitine significantly decreases the nephrectomy- E kinase activity. Tubular hypertrophy, assayed as an
induced increase in cyclin E activity. Despite inhibition increase in the protein:DNA ratio of isolated proximal
of cyclin E kinase, Roscovitine has no effect on the tubules, is clearly evident at day 10. At this time point,
development of hypertrophy following uninephrectomy. cyclin D activity has been increased, whereas cyclin E
In both sham and nephrectomized rats, Roscovitine in- activity has been inhibited for a number of days. Thus,
creases cyclin D activity. In sham rats, the activation of diabetic-induced tubular epithelial growth initially in-
cyclin D and the inhibition of cyclin E by Roscovitine volves proximal tubule hyperplasia, followed later by
causes the development of hypertrophy, even without hypertrophy. As the hyperplasia is associated with acti-
the loss of renal mass, demonstrating that the pattern of vation of both cyclin D and E kinases and the hypertro-
kinase regulation plays a role in the development of phic growth period associated with only cyclin D kinase
hypertrophy. activation, this form of renal epithelial cell hypertrophy
The role of NH3 in compensatory renal hypertrophy also involves a cell cycle-dependent mechanism.
was examined by feeding sham and uninephrectomized
rats an alkaline diet and comparing them with rats receiv-
SUMMARYing the same diet to which NaCl was added. In sham
rats, the alkaline diet decreases renal NH3 excretion, In summary, in in vivo [compensatory renal growth,
suggestive of a decrease in ammoniagenesis. However, diabetic nephropathy, and the reparative phase following
the alkaline diet has no effect on the protein:DNA ratio an episode of transient ischemia (data not discussed)]
of isolated proximal tubules in sham or nephrectomized as well as in vitro (cultured renal epithelial cell) renal
rats, suggesting that ambient renal [NH3] does not play epithelial cell growth models, cyclin D kinase activity is
a role in compensatory renal growth following uni- associated with the physical growth that occurs in hyper-
nephrectomy. As a control, the effect of an alkaline diet plasia and some forms of hypertrophy. In these condi-
on chronic hypokalemic-induced renal growth was exam- tions in which cyclin D kinase is activated, the level of
ined. Compared with control rats, chronic hypokalemia cyclin E kinase activity determines entrance into S phase
increases renal ammonia excretion and leads to an in- and thus defines the growth pattern as hypertrophy or
crease in kidney size (assayed as the kidney:body weight hyperplasia. The distinct pattern of kinase activity per-
ratio). The addition of alkali to the K-deficient diet de- mits classification of renal hypertrophy in clinical condi-
creases renal ammonia excretion and returns the kid- tions as being mediated by a cell cycle-dependent or
ney:body weight ratio back toward control values. Thus, -independent process. The latter is not discussed in this
in chronic hypokalemic, but not compensatory renal article (abstract; Liu and Preisig, J Am Soc Nephrol
growth, ambient renal NH3 appears to play a role in the 9:444A, 1998; abstract; Huang and Preisig, J Am Soc
renal growth. Nephrol 9:440A, 1998) [1, 2, 6, 7, 15].
Taken together, these studies characterize compensa-
tory renal hypertrophy as a cell cycle-dependent process. ACKNOWLEDGMENTS
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